These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 38134881)

  • 21. FKBP3 Induces Human Immunodeficiency Virus Type 1 Latency by Recruiting Histone Deacetylase 1/2 to the Viral Long Terminal Repeat.
    Yang X; Zhao X; Zhu Y; Shen Y; Wang Y; Lu P; Jiang Z; Pan H; Yang J; Xun J; Zhao L; Wang J; Liang Z; Shen X; Liang Y; Lin Q; Liang H; Jin L; Zhang D; Liu J; Wang B; Jiang S; Xu J; Wu H; Lu H; Zhu H
    mBio; 2021 Aug; 12(4):e0079521. PubMed ID: 34281390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitors.
    Archin NM; Keedy KS; Espeseth A; Dang H; Hazuda DJ; Margolis DM
    AIDS; 2009 Sep; 23(14):1799-806. PubMed ID: 19590405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic regulation of HIV-1 latency in astrocytes.
    Narasipura SD; Kim S; Al-Harthi L
    J Virol; 2014 Mar; 88(5):3031-8. PubMed ID: 24352441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flavonoid-based inhibition of cyclin-dependent kinase 9 without concomitant inhibition of histone deacetylases durably reinforces HIV latency.
    Schonhofer C; Yi J; Sciorillo A; Andrae-Marobela K; Cochrane A; Harris M; Brumme ZL; Brockman MA; Mounzer K; Hart C; Gyampoh K; Yuan Z; Montaner LJ; Tietjen I
    Biochem Pharmacol; 2021 Apr; 186():114462. PubMed ID: 33577894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PIWIL4 Maintains HIV-1 Latency by Enforcing Epigenetically Suppressive Modifications on the 5' Long Terminal Repeat.
    He Z; Jing S; Yang T; Chen J; Huang F; Zhang W; Peng Z; Liu B; Ma X; Wu L; Pan T; Zhang X; Li L; Cai W; Tang X; Zhang J; Zhang H
    J Virol; 2020 May; 94(10):. PubMed ID: 32161174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A CRISPR/Cas9 screen identifies the histone demethylase MINA53 as a novel HIV-1 latency-promoting gene (LPG).
    Huang H; Kong W; Jean M; Fiches G; Zhou D; Hayashi T; Que J; Santoso N; Zhu J
    Nucleic Acids Res; 2019 Aug; 47(14):7333-7347. PubMed ID: 31165872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histone deacetylase inhibitors and HIV latency.
    Margolis DM
    Curr Opin HIV AIDS; 2011 Jan; 6(1):25-9. PubMed ID: 21242890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In Vitro Reactivation of Replication-Competent and Infectious HIV-1 by Histone Deacetylase Inhibitors.
    Banga R; Procopio FA; Cavassini M; Perreau M
    J Virol; 2016 Feb; 90(4):1858-71. PubMed ID: 26656693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A New Quinoline BRD4 Inhibitor Targets a Distinct Latent HIV-1 Reservoir for Reactivation from Other "Shock" Drugs.
    Abner E; Stoszko M; Zeng L; Chen HC; Izquierdo-Bouldstridge A; Konuma T; Zorita E; Fanunza E; Zhang Q; Mahmoudi T; Zhou MM; Filion GJ; Jordan A
    J Virol; 2018 May; 92(10):. PubMed ID: 29343578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator Tat.
    He G; Margolis DM
    Mol Cell Biol; 2002 May; 22(9):2965-73. PubMed ID: 11940654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histone deacetylase inhibitor chidamide promotes reactivation of latent human immunodeficiency virus by introducing histone acetylation.
    Kuai Q; Lu X; Qiao Z; Wang R; Wang Y; Ye S; He M; Wang Y; Zhang T; Wu H; Ren S; Yu Q
    J Med Virol; 2018 Sep; 90(9):1478-1485. PubMed ID: 29704439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A limited group of class I histone deacetylases acts to repress human immunodeficiency virus type 1 expression.
    Keedy KS; Archin NM; Gates AT; Espeseth A; Hazuda DJ; Margolis DM
    J Virol; 2009 May; 83(10):4749-56. PubMed ID: 19279091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV Provirus Stably Reproduces Parental Latent and Induced Transcription Phenotypes Regardless of the Chromosomal Integration Site.
    Hashemi FB; Barreto K; Bernhard W; Hashemi P; Lomness A; Sadowski I
    J Virol; 2016 Jun; 90(11):5302-14. PubMed ID: 26984732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histonedeacetylase inhibitor Oxamflatin increase HIV-1 transcription by inducing histone modification in latently infected cells.
    Yin H; Zhang Y; Zhou X; Zhu H
    Mol Biol Rep; 2011 Nov; 38(8):5071-8. PubMed ID: 21181272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective histonedeacetylase inhibitor M344 intervenes in HIV-1 latency through increasing histone acetylation and activation of NF-kappaB.
    Ying H; Zhang Y; Zhou X; Qu X; Wang P; Liu S; Lu D; Zhu H
    PLoS One; 2012; 7(11):e48832. PubMed ID: 23166597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quiescence Promotes Latent HIV Infection and Resistance to Reactivation from Latency with Histone Deacetylase Inhibitors.
    Painter MM; Zaikos TD; Collins KL
    J Virol; 2017 Dec; 91(24):. PubMed ID: 29021396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene silencing in HIV-1 latency by polycomb repressive group.
    Kim HG; Kim KC; Roh TY; Park J; Jung KM; Lee JS; Choi SY; Kim SS; Choi BS
    Virol J; 2011 Apr; 8():179. PubMed ID: 21496352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel histone deacetylase inhibitor NCH-51 activates latent HIV-1 gene expression.
    Victoriano AF; Imai K; Togami H; Ueno T; Asamitsu K; Suzuki T; Miyata N; Ochiai K; Okamoto T
    FEBS Lett; 2011 Apr; 585(7):1103-11. PubMed ID: 21402072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic silencing of HIV-1 by the histone H3 lysine 27 methyltransferase enhancer of Zeste 2.
    Friedman J; Cho WK; Chu CK; Keedy KS; Archin NM; Margolis DM; Karn J
    J Virol; 2011 Sep; 85(17):9078-89. PubMed ID: 21715480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Naf1 Regulates HIV-1 Latency by Suppressing Viral Promoter-Driven Gene Expression in Primary CD4+ T Cells.
    Li C; Wang HB; Kuang WD; Ren XX; Song ST; Zhu HZ; Li Q; Xu LR; Guo HJ; Wu L; Wang JH
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.